Motilal Oswal Asset News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Motilal oswal asset. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Motilal Oswal Asset Today - Breaking & Trending Today

After partying hard in Dec, will equity bulls turn fatigue in New Year? See what history shows

But after partying hard in the last couple of months, fatigue among bulls is likely to be seen entering into the New Year, shows various data indicators. ....

Sriram Velayudhan , Aniket Shah , Abhilash Pagaria , Nuvama Quantitative Research , Dalal Street , New Year , Motilal Oswal Asset , Nuvama Quantitative , Equity Bulls , Capital Flows , Oil Prices , Profit Booking , Foreign Portfolio Investors ,

macro economic stability: ETMarkets Fund Manager Talk: 2024 could be a period of lower returns compared to 2023, says this Rs 22,000-crore fund manager

Niket Shah says: "2024 could be a year of lower returns as compared to 2023. This is because some of the tailwinds which caused this years outperformance (lower oil prices, easy domestic liquidity, certainty on political front) are likely to be missing next year. Nonetheless, given that we should see lower interest rates next year it should result in 8-10% returns for 2024 which will be lower than 2023." ....

Uttar Pradesh , Aniket Shah , Indian School Of Business , Offering College , Motilal Oswal Asset , Leadership Excellence , Operations Officer , Executive Officer , Might Also Like , Dalal Street , Macro Economic Stability , Capital Flows , Indian Equity Market , Growth Surprises , Fund Manager , Oasis Of Growth , Motilal Oswal Asset Management , Expert View , Stock Market ,

Pharma: Pharma cos' likely re-rating, strong outlook to sustain rally

In the past month, Sun Pharma gained 7%, Aurobindo Pharma jumped 20%, Lupin and Mankind Pharma rose 9% each. The gains have pushed these stocks to their 52-week highs. The Nifty Pharma Index has gained 8% in the past month, as against the 3.4% upmove in the Nifty. ....

Sun Pharma , Aurobindo Pharma , Aniket Shah , Rajesh Palviya , Mankind Pharma , Nifty Pharma Index , Motilal Oswal Asset , Pharma Index , Nifty Pharma ,

Wealthy Indians are increasingly dialing PMS to generate Alpha; here's why

An increasing number of wealthy Indians are looking at portfolio management services (PMS) to manage their wealth and generate returns higher than the market or mutual funds. While assets have nearly trebled in the past seven years, the elite money managers have never been more bullish - Issue Date: Aug 06, 2023 ....

Tamil Nadu , West Bengal , Rashim Bagga , Sunil Rohokale , Manish Sonthalia , Saurabh Mukherjea , Jiten Doshi , Association Of Mutual Funds , Even The Association Of Portfolio Managers , Exchange Board Of India Sebi , Hurun India Rich List , Exchange Board , Chief Investment Officer , Mutual Funds , Motilal Oswal Asset , Hurun India , Marcellus Investment Managers , Portfolio Managers , Principal Officer , Portfolio Management Services , Mutual Fund , Wealthy Indians , High Net Worth Individuals , Stock Market , Hare Market Issue Date Aug 06 ,

With 8% gains YTD, India still underperforming in global bull race; will it catch up?

Thanks to foreign investors relentless buying, the benchmark Nifty50 and Sensex have risen more than 15% from the March lows and reached new highs. Indian equities also joined the club of the best-performing markets in 2023. However, compared to other emerging and developed market peers, India underperforms. ....

Aditya Khemani , Geojit Financial Services , Nasdaq Composite , Taiwan Weighted , Reserve Bank , Motilal Oswal Asset , Geojit Financial , Economic Times , Fii Buying ,